Načítá se...
Enhancing antibody patent protection using epitope mapping information
As the $100B therapeutic monoclonal antibody (mAb) market continues to grow, developers of therapeutic mAbs increasingly face the need to strengthen patent protection of their products and enforce their patents in courts. In view of changes in the patent law landscape, patent applications are strate...
Uloženo v:
| Vydáno v: | MAbs |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5825199/ https://ncbi.nlm.nih.gov/pubmed/29120697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2017.1402998 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|